Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis by Steinsbekk, Aslak et al.
Steinsbekk et al. BMC Health Services Research 2012, 12:213
http://www.biomedcentral.com/1472-6963/12/213RESEARCH ARTICLE Open AccessGroup based diabetes self-management
education compared to routine treatment for
people with type 2 diabetes mellitus. A
systematic review with meta-analysis
Aslak Steinsbekk1*, Lisbeth  Rygg1, Monde Lisulo1, Marit B Rise1 and Atle Fretheim2,3Abstract
Background: Diabetes self-management education (DSME) can be delivered in many forms. Group based DSME is
widespread due to being a cheaper method and the added advantages of having patient meet and discuss with
each other. The aid was to assess effects of group-based DSME compared to routine treatment on clinical, lifestyle
and psychosocial outcomes in type-2 diabetes patients.
Methods: A systematic review with meta-analysis. Computerised bibliographic database were searched up to
January 2008 for randomised controlled trials evaluating group-based DSME for adult type-2 diabetics versus
routine treatment where the intervention had at least one session and =/>6 months follow-up. At least two
reviewers independently extracted data and assessed study quality.
Results: In total 21 studies (26 publications, 2833 participants) were included. Of all the participants 4 out of 10
were male, baseline age was 60 years, BMI 31.6, HbA1c 8.23%, diabetes duration 8 years and 82% used medication.
For the main clinical outcomes, HbA1c was significantly reduced at 6 months (0.44% points; P = 0.0006, 13 studies,
1883 participants), 12 months (0.46% points; P = 0.001, 11 studies, 1503 participants) and 2 years
(0.87% points; P< 0.00001, 3 studies, 397 participants) and fasting blood glucose levels were also significantly
reduced at 12 months (1.26 mmol/l; P< 0.00001, 5 studies, 690 participants) but not at 6 months. For the main
lifestyle outcomes, diabetes knowledge was improved significantly at 6 months (SMD 0.83; P = 0.00001, 6 studies,
768 participants), 12 months (SMD 0.85; P< 0.00001, 5 studies, 955 participants) and 2 years (SMD 1.59; P = 0.03,
2 studies, 355 participants) and self-management skills also improved significantly at 6 months (SMD 0.55; P = 0.01,
4 studies, 534 participants). For the main psychosocial outcomes, there were significant improvement for
empowerment/self-efficacy (SMD 0.28, P = 0.01, 2 studies, 326 participants) after 6 months. For quality of life no
conclusion could be drawn due to high heterogeneity. For the secondary outcomes there were significant
improvements in patient satisfaction and body weight at 12 months for the intervention group. There were no
differences between the groups in mortality rate, body mass index, blood pressure and lipid profile.
Conclusions: Group-based DSME in people with type 2 diabetes results in improvements in clinical, lifestyle and
psychosocial outcomes.
Keywords: Patient education as topic, Self-care, Type 2 diabetes mellitus, Systematic review* Correspondence: aslak.steinsbekk@ntnu.no
1Department of Public Health and General Practice, Norwegian University of
Science and Technology, Post box 8905, Medisinsk teknisk forskningssenter,
7491, Trondheim, Norway
Full list of author information is available at the end of the article
© 2012 Steinsbekk et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Steinsbekk et al. BMC Health Services Research 2012, 12:213 Page 2 of 19
http://www.biomedcentral.com/1472-6963/12/213Background
Diabetes mellitus is one of the most common chronic
disorders in the western world. In 2007, it was estimated
that there were 246 million people (7.3% of adults aged
20-79) with diabetes compared to194 million in 2003
[1]. Type 2 diabetes constitutes about 85% to 95% of all
diabetes cases in developed countries.
The World Health Organisation Report on therapeutic
patient education recognises the importance of patient-
centred education in the effective management of chronic
diseases [2]. Therapeutic patient education is education
designed to help a patient (or a group of patients and
their families) to manage their treatment and prevent
avoidable complications, while keeping or improving
their quality of life. It has been recognised that adoption
of self-management skills (i.e. the learned ability to per-
form and act competently) by persons with diabetes is
necessary to enable them to manage their diabetes.
In diabetes self-management education (DSME), the
close involvement of patients and care givers is encour-
aged. In contrast, traditional education is didactic in na-
ture and tends to be delivered in lecture format. There are
several initiatives to provide guidelines for DSME. The
International Diabetes Federation has published 'Inter-
national Curriculum for Diabetes Health Professional
Education' International [3] and 'International Standards
for Diabetes Education' [4]. In the United States of Amer-
ica a 'National Standards for Diabetes Self-Management
Education' has also been developed and regularly updated
[5]. In the UK, the Department of Health has published
the “Structured Patient Education in Diabetes” [6].
However, there are considerable variations in the con-
tent and form of DSME and thus no standardised de-
scription can be given of the intervention. Educational
programs are frequently defined as complex interven-
tions where it is often difficult to define the 'active in-
gredient' framework [7]. If a program is shown to be
effective, that may be due to any combination of the the-
oretical model used, the skills of the educator, the venue,
the rapport between the participants and so on. How-
ever, if sufficiently homogeneous good quality complex
interventions are systematically reviewed, the active in-
gredient is more likely to become apparent.
In a Diabetes UK commissioned review from 1998 on
the educational and psychosocial interventions for adults
with diabetes [8], six meta-analyses were identified [9-14],
one review [15] and 57 published controlled trials. Thus,
a large number of trials have been undertaken early,
mainly in secondary care in the United States. More re-
cent reviews have evaluated the effects of different types
of self-management training in type 2 diabetes [16-27]
Although there is evidence that self-management train-
ing is effective, most reviews called for further research
by way of well-designed and long-term studies.None of the above reviews have had a comprehensive
evaluation of the effect of diabetes self-management
education delivered in a group format. This was done
for studies up to 2003 by Deakin et.al. [28] where it was
found that group based DSME had a significant effect
on clinical, lifestyle and psychosocial outcomes. Group
based DSME is widespread due to being a cheaper method
and the added advantages of having patient meet and
discuss with each other.
The current review builds on the previous review [28].
The aim of this study was thus to assess effects of
group-based DSME compared to routine treatment on
clinical, lifestyle and psychosocial outcomes in type-2
diabetes patients.
Methods
This was a systematic review with meta-analysis of ran-
domised controlled trials (RCT's) comparing group-
based diabetes self-management education with routine
treatment, waiting list control or no intervention. Only
studies that assessed outcome measures six months or
more from baseline were included in this review.
Participants
Studies which included adults diagnosed with type 2 dia-
betes. There were no criteria for how the type 2 diabetes
should have been diagnosed, but ideally it should have
been described. In order to be consistent with changes
in classification and diagnostic criteria of the disease
through the years, the diagnosis should have been estab-
lished using the standard criteria that were valid at the
beginning of the trial.
Interventions
Studies were included if the intervention described was
group-based education specific for people with type 2
diabetes and if the duration of education was a mini-
mum of one session lasting for one hour. Furthermore,
the control group must have been given the routine
treatment (standard of care recommended), remained on
a waiting list or received no intervention (i.e. the present
healthcare was continued).
Outcomes
The time points for measurement were divided into
short term (6 months - range 4 to 8 months) and long
term (12 months - range 9 to 16 months) and 2 years or
more (range 17 months or more). The main outcomes
were Clinical (metabolic control measured by glycated
haemoglobin and fasting blood glucose), Lifestyle (dia-
betes knowledge and self-management skills) and Psy-
chosocial (quality of life and empowerment/self-efficacy).
The secondary outcomes were; Body weight; Body mass
index (BMI); Blood pressure (systolic/diastolic); Lipid
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terol, triglycerides); Patient treatment satisfaction and
Death.
Search and study selection
For studies that were published up 2003 we relied on the
searches and assessments that were conducted for the
existing Cochrane review on diabetes self-management
education delivered in group format [28]. A new search
of Ovid MEDLINEW, The Cochrane Library, EMBASE,
ERIC and PsycINFO was done for publications from
2003 to week 2 in 2008. Resources were also hand-
searched through reference lists of articles and other
reviews and contact with experts in the field. An example
of the search strategy used for electronic searches is
given in appendix A.
Two reviewers independently scanned the titles, ab-
stract sections and/or keywords of every record
retrieved. Full articles were retrieved for further assess-
ment if the available information suggested that the
study met the inclusion criteria. If there was any doubt
regarding the fulfilment of these criteria, the complete
articles were retrieved. Any differences in opinion were
discussed and, if necessary, resolved by a third party.
Data extraction and data entry were performed inde-
pendently in duplicate by two reviewers. Differences in
data extraction were discussed and if necessary resolved
by a third reviewer.
If data was missing in a published report, the reviewers
tried to contact the first author. If the values given in
the publications were not in a form that could be used
in the meta-analysis, the values were recalculated if pos-
sible using the directions given in the Cochrane hand-
book [29]. If the standard deviations were not given for
the follow up values, the baseline standard deviations
were used. The re-calculations concerned converting
fasting blood glucose and lipid level data from milli-
grams per decilitre (mg/dl) to mill moles per litre
(mmol/l) and calculating the standard deviation for
values where it was not provided.
Analysis
The methodological quality of the trials was assessed in-
dependently by two reviewers using the Risk of Bias ap-
proach described in the Cochrane Handbook [30]. This
involves a description and a judgement for random se-
quence generation, allocation concealment, blinding, in-
complete outcome data, selective outcome reporting and
other potential sources of bias. ‘Low risk’ indicating low
risk of bias, ‘High risk’ indicating high risk of bias, and
‘Moderate risk’ indicating either lack of information or
uncertainty over the potential for bias. Any disagree-
ments about methodological quality were resolved by
discussions.To describe the weighted average participant at base-
line for included studies, the mean baseline value for
each study was multiplied with the number of partici-
pants in the study. This was summarised across the
studies and divided by the total number of participants.
For all analyses the DerSimonian and Laird method
provided in Review manager v5 was used. A random ef-
fect approach was chosen for all analyses because it was
not likely that the underlying data represented one true
effect due to the differences in the populations and
interventions in the different studies. For analyses of
continuous data where the same measurement was used
across studies, the mean difference was calculated. If the
same underlying concept was measured but different
outcome measurements were used, standardised mean
difference (SMD) was calculated. For analyses of cat-
egorical data odds ratio (OR) was calculated. At the out-
set, a meta-analysis was conducted for all relevant
outcomes with more than one study reporting results.
Mean outcome data at each time point were compared
for the main analyses. Mean change from baseline to
12 months of HbA1c was used for the subgroup and
sensitivity analyses.
To test for heterogeneity, I2, which describes the per-
centage of total variation across studies that was due to
heterogeneity rather than sample error (chance) [31],
was used. If I2 was from 60% and above, a sensitivity
analysis was done by removing the studies contributing
to the heterogeneity and reporting this result as well. In
the representation of the analysis in the tables, all the
studies are included.
Change in HbA1c from baseline to 12 months was used
for the subgroup and sensitivity analyses. This was calcu-
lated using the difference in absolute value at 12 months
and subtracting the baseline value. The standard deviation
(SD) was calculated taking the average of the baseline and
12 months SD.
Separate analyses of the effect on HbA1c at 12 months
were performed for the following subgroups:1. Ethnicity. Studies with participants who were mostly
non-Caucasian.
2. Used theoretical model. Studies that explicitly stated
that they had a theoretical model underpinning the
education programme.
3. Type of educators. Studies that had one type of
educator that delivered the programme to the
participants and for those that had more than one
person engaged as an educator.
4. Primary care. Studies that were delivered in primary
care.
5. Baseline HbA1c level. Studies where the mean
HbA1c baseline value was 7% or more.
Figure 1 Stages of study identification.
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received follow-up education sessions or telephone
calls.
7. Length of delivery. Studies where delivery of
education programme was completed in 5 months or
less, between 6 and 10 months and in 10 months or
more.
8. Total number of hours. Total hours of education
provided excluding follow up sessions, divided in
quartiles.
9. Attendance rate. Studies with overall attendance rate
less than 70%.
10.Number of participants. Number of participants in
each group session.
11.Family and friends. Studies including family and
friends as participants.
12.Number of sessions. Total number of sessions
provided excluding follow up sessions, divided in
three groups.
Sensitivity analyses for each outcome were performed
in order to explore the influence of the following factors
on HbA1c at 12 months:
1. Language of publication English. Analysis of studies
that were not translated (i.e. excluding studies which
had been published in a foreign language and then
translated to English).
2. Number of participants in the study. Analysis of
studies with the total number of participants more
than the median of all the studies.
3. Recalculated values. Analyses of studies where some
of the values were recalculated because they were
reported in a format not usable in a meta-analysis.
4. Risk of bias (Study quality). Separate analysis of
studies which were scored as low, moderate or high
risk of bias.
5. Drop out. Analysis of studies with less than 10%
overall dropout rate.
Results
The original literature search conducted for the existing
Cochrane review (to January 2003) [28] yielded 4598
citations and our updated search 2347 citations after ex-
cluding duplicates, giving a total of 6945 citations. A
flow chart indicating the stages of study identification is
included as Figure 1. A total of 292 citations either met
the inclusion criteria or required sight of full paper be-
fore a decision could be made. Finally 266 publications
were excluded and 21 studies reported in 26 publications
were included.
Among the 266 publications that were excluded, five
were included in the original Cochrane review (Domenech
1994; Domenech 1995; Kronsbein 1988; Pieber 1995;Rickheim 2002). They were excluded from the current
review due to not being randomised trials. The reasons
for the exclusion of the other publications included: lack
of control group; length of follow-up being too short; ab-
sence of the pre-specified outcomes; intervention group
in receipt of individual appointments in addition to the
group-based education programme; delivery of group-
based education programme to the control group; not all
participants having type 2 diabetes; narrative papers,
non-randomised trial, duplicate paper, irrelevant out-
comes, results presented in format not usable in a meta-
analysis, and group-based education programme that did
not focus on diabetes self-management education. Sev-
eral studies were excluded on more than one ground.
Description of participations and studies
Twenty-one studies reported in 26 publications were
included [32-56] (Table 1). Among these, five reported
on the same studies by either reporting other outcome
measures [50] or long term follow-up data [52-54]. In
the first review; data from one unpublished study were
included [57]. For this review, this has been replaced
with the published data of the same study [38]. One
publication reporting on a 3 armed study had data for
the intervention groups combined to create one inter-
vention group [44].
A total of 2833 participants were included in the 21
studies with 1454 (51%) in the intervention group. Four
out of ten participants were male and at baseline the
pooled average age was 60 years (SD 9.5), BMI 31.5 (SD
5.6), diabetes duration was 8.1 years (SD 7.0), HbA1c
level 8.23% (SD 1.80), and 81.9% used insulin and/or oral
glucose lowering agents. The analyses showed that there
were no significant differences between the intervention
Table 1 Characteristics of studies included in the systematic review of randomized controlled trials assessing group based diabetes self-management
education compared to routine treatment for people with type 2 diabetes mellitus
Author
Year,
Country,
Number of
participants
recruited / at
follow-up
Mean age (SD
or range) years
Mean
duration
of diabetes
(years)
Mean (SD) %
HbA1c at
baseline
(Intervention /
Control)
Inclusion
criteria
Intervention Follow-up
(months or years)
Risk of
bias
Adolfsson 2007,
Sweden
101/88 63.0 (9.0) 6.6 (4.1) 7.1 (1.0)/
7.1 (0.8)
Diabetes type 2
duration of at least
1 year, receiving
dietary or oral
anti-diabetes
treatment
4-5 sessions of 2.5 hours
each and one follow-up session
within 28 weeks, (12.5 hours), by
trained physicians and diabetes
specialist nurses
1 year Low
Baradaran 2006, UK 118/80 58.5 (12.0) 9.0 (7.5) Not stated South Asians,
type 2 diabetes,
> 30 years of age
3 sessions of 2,5 hours + 25 minutes
information video (7.5 hours),
by dietician and podiatrist
6 months Moderate
Brown 2002, USA 256/230 54.1 (8.3) 7.9 (6.4) 11.8 (3.0)/
11.8 (3.0)
Mexican Americans 52 hours over 12 months
(3 mths of weekly 2 hrs sessions,
6 mths of biweekly 2 hrs sessions,
3 mths of monthly 2 hrs sessions),
by nurse, dietician & community
worker
1 year High
35-70 years,
diagnosed with
Type 2 diabetes,
2 measures of FBG>
140 mg/dl, taken
insulin or oral
hypoglycaemic
agents for >1 year
Cabrera-Pivaral 2004,
Mexico,
49/49 58.0 (10.6) 10.0 (10.4) Not stated Hispanics, obese
type 2 diabetics
82 hours over 9 months
(2 hours/week), by social worker
and nutritionist
9 months High
Clancy 2007, USA 186/159 56 (8.9) Not stated 9.3 (2.0)/
8.9 (2.1)
African Americans
with poorly controlled
diabetes type 2
(HbA1c> 8.0 %),
1 group visit/month for
12 months, 2 hours/visit
(24 hours), by
physician and registered nurse.
1 year Moderate
Cooper 2003, UK 89/Not stated 58 (30-73) 6 (1-30) 7.9 (1.7)/
7.0 (1.6)
Type 2 diabetics, oral
hypoglycaemic agents
treatment
8 weekly sessions for 2 hours
(16 hours), by diabetes
specialist nurses
1 year Moderate
Deakin 2006, UK 314/291 61.6 (10.4) 6.7 (6.6) 7.7 (1.6)/
7.7 (1.6)
Adults with type 2
diabetes identified
from practice registers
using WHO criteria
2 hours per week for 6 weeks
(12 hours), by diabetes research
dietician/diabetes educator
14 months Low
Heller 1988, UK 87/75 56.4 (8.5) Not stated 12.3 (2.8)/
12.7 (2.5)
Newly diagnosed age
30-75 yrs
4.5 hr for 3 consecutive weeks,
1.5 hr at both 3 & 6 months
(7.5 hours), by diabetes nurses
and a dietician
1 year Moderate
Holtrop 2002, USA 132/88 61.5 (No SD or range) Not stated 8.0 (1,34)/
7.7 (1,34)
More than 40 years,
female type 2 diabetics,
HbA1c> 7 % in past
6 months
Six weekly 1 1/2 hour sessions
(9 hours), by trained lay health
advisors
6 months Moderate
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Table 1 Characteristics of studies included in the systematic review of randomized controlled trials assessing group based diabetes self-management
education compared to routine treatment for people with type 2 diabetes mellitus (Continued)
Hornsten 2004,
Sweden
104/99 63.5 (9.2) Not stated 5.7 (0.8)/
5.8 (0.7)
Aged 40 - 80 years,
diagnosed with type
2 diabetes during the
previous 2 years.
Oral, guts and/or insulin,
and diet treatment
10 group sessions, 2 hours/session
for 9 months (20 hours), by
diabetes nurses
1 year Moderate
Lozano 1999, Spain 243/234 64.3 (11.2) 8.6 (8.3) 6.6 (1.4)/
6.7 (1.3)
Type 2 diabetes 1 hr 30 min/day for two consecutive
days (3 hours), and further education
in year two, by nurses
2 years Moderate
Lujan 2007, USA 149/140 Not stated Not stated 8.2 (2.2)/
7.7 (1.5)
40 years of age or older,
Self reported Mexican-
American ethnicity,
Diagnosed with type
2 diabetes for at least 1 year,
Taking or having taken
hypoglycemic agents within
the past 6 months.
2 hour long sessions for 8 weeks
(16 hours) plus biweekly telephone,
by Promotoras (Community
lay workers)
6 months High
Mayer-Davies 2004,
USA
152/ Not stated 60.4 (8.7) 11.0 (9.4) 9.7 (2.8)/
9.6 (2.9)
Clinical diagnosis of diabetes,
BMI of 25 kg/m2 or greater
during the previous
calendar year
Intense: 1 hour weekly for four mths,
biweekly for two mths and once
every moth for six mths, by
Nutritionist
1 year High
Reimbursable: Four 1 hour sessions
(3 group sessions & 1 individual
session) over 12 months, by
Nutritionist
McKibbin 2006, USA 64/57 54.0 (9.3) 8.7 (6.2) 7.4 (2.9)/
6.7 (2.1)
Older schizophrenic patients.
Diet, Oral agents, and
Insulin treatment
24 weekly 90 minute sessions
for 6 months (36 hours).
6 months Moderate
Pennings-van der
1991, Netherlands
118/83 64.4 (9.6) 10.9 (7.6) 8.0 (1.8)/
7.6 (1.5)
Diabetes mellitus type Il
treated with diet and/or
oral agents
7 half-day meetings in 7 weeks,
by physicians, dieticians,
diabetologist, diabetes nurse
8 months High
Rosal 2005, USA 25/Not stated 62.6 (8.7) 8.2 (5.6) 7.7 (1.2)/
9.3 (1.8)
Hispanics. Diet, Oral
hypoglycemic agents, Insulin,
Alternative medicines
treatment
Initial 1 hour individual session,
followed by 10 weekly 2.5 to 3 hour
group sessions and two 15 minute
individual sessions that occurred
immediately prior to the group
session (30 hours), by Diabetes
nurse, Nutritionist and an Assistant
6 months High
Sarkadi 2004, Sweden 77/64 66.4 (9.3) 4.3 (4.0) 6.5 (1.5)/
6.4 (1.5)
Type 2 diabetes, treated
with insulin only for 2 year
or less
Meetings every months over
12 months, by Pharmacists assisted
by Diabetes nurse specialists the
two first meetings
2 years Moderate
Toobert 2003/2007,
USA
279/215 60.9 (7.9) 8.3 (7.7) 7.4 (1.3)/
7.4 (1.5)
Female, Diagnosis of type
2 diabetes for at least
6 months, Postmenopausal,
3 days non-residential retreat,
followed by 4-hour weekly meetings
for 6 months
6 months [49];
24 months ([50])
Moderate
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Table 1 Characteristics of studies included in the systematic review of randomized controlled trials assessing group based diabetes self-management
education compared to routine treatment for people with type 2 diabetes mellitus (Continued)
Trento 1998/2001/
2002/2004, Italy
112/84 61.5 (30-80) 9.6 (1-39) 7.2 (1.3)/
7.3 (1.4)
Treated with diet or oral
hypoglycaemic agents,
followed in clinic >1 year
Every 3 months for 1 year
(4 x 60/70 min), and 15-30 min.
individually for those who
developed specific problems[51];
every 3 months for 2 years
(1 hour x 8 = 8 hr/2 yr) ([52]); every
3 months for 2 years and 7 sessions
in year 3 +4 (total 15 hrs/4 yrs)
([53]); every 3 months for 2 years
and 7 sessions in year 3and 4
(total 15 hrs/4 yrs) and started
again in year 5 ([54]), by Two
physicians and educationist
1 year [51],
2 years ([52]),
4 years ([53]),
5 years ([54])
Moderate
Wattana 2007,
Thailand
157/147 56.8 (10.1) 6.2 (5.0) 8.1 (1.9)/
8.1 (2.0)
35 years or older, Diagnosed
with type 2 diabetes for at
least 6 months, Fasting
plasma glucose level
>140 mg for at
least 2 follow up visits, Asian
participants. Oral hypoglycaemic
agents treatment
120 minutes small group diabetes
education class, 4 small group
discussions (90 mins/group),
two 45 minutes home visits
by the researcher
6 months Moderate
Zapotoczky 2001,
Austria
36/36 57.5 (9.8) Not stated 8.6 (1.6)/
8.0 (1.5)
Not stated 1.5 hours monthly for
10 months
(15 hours) delivered
by a dietician
1 years High
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average HbA1c level in the intervention group was 8.31
(SD 1.83) and in the control group 8.16 (SD 1.76); a
non-significant weighted mean difference of 0.09 (95%CI
-0.05 to 0.23, p = 0.21) (Table 2, Analysis 1.5).
Three of the 26 publications required translation; two
were written in Spanish [35,42] and one in Dutch
[46]. Eight studies were carried out in the United
States [34,36,40,43-45,47,49,50], four in the United
Kingdom [33,37-39], three in Sweden [32,41,48], one
in Austria [56], one in Mexico [35], one in Thailand
[55], one in Spain [42], one in the Netherlands [46]
and one in Italy [51-54].
The length of follow-up was six months for 8 of the
trials [33,40,43,45-47,49,55], 12 months for 11 of the
trials [32,34-39,41,44,51,56], and two years for two trials
[42,48]. The Toobert study had follow-up at two years
[50] and the Trento study also had follow-up at two
years [52], four years [53] and five years [54]. The dur-
ation of the DSME varied with the least intensive being
three hours per year for two years [42]. Ten trials
described programmes that ranged from six to twenty
hours of group-based education over a period of be-
tween four weeks and 10 months [32,36-41,43,46,56].
The most intensive education programmes were
52 hours over one year [34], 36 hours over 6 months
[45], 30 hours over 2.5 months [47] and 96 hours over
6 months [50].
The settings in twelve of the 21 studies were primary
care [32-34,36,38,41,42,44-47,49,50], and five were deliv-
ered in hospital diabetes centres [39,43,51-56]. Four
studies did not indicate the settings in which the educa-
tion programmes were held [39,43,51-56].
The educators were all health professionals, with the
exception of two studies where the educators were lay
health advisors or community workers [40,43]. Four of
the DSMEs were delivered by physicians in association
with other health personnel [32,36,46,51-54]. Four DSMEs
were delivered by a dietician and a nurse [33,34,39,49,50]
with some also involving community workers and other
health personnel [33,34,49,50]. Two programmes were
delivered by dieticians working alone [38,56], one by a
nurse working alone [42] and one by a nutritionist workingTable 2 Baseline values
Analysis number / Outcome Effect measure N studies
1.1 Sex (% males) Odds Ratio 17
1.2 Age Mean Diff 17
1.3 Body mass index Mean Diff 16
1.4 Duration of disease (years) Mean Diff 13
1.5 HbA1c Mean Diff 19
1.6 Use of OHA and/or Insulin Odds Ratio 12alone [44]. Four studies reported the programmes being
delivered by diabetes specialist nurses in collaboration
with other health personnel [37,41,47,48].
Four studies reported that a family member or friend
alsowas invited to attend the programme [34,39,46,51-53].
The theoretical model used to plan the DSME was
reported in ten studies. Five studies described single the-
ories while the remaining five used a combination of
theories. The single theories were social cognitive theory
[45,47], empowerment model [32,43], and systematic
education approach [51-54]. The combination of theor-
etical models were the empowerment model, theories of
planned behaviour and personal models of sickness [37],
the empowerment model and the discovery learning the-
ory [38], the social cognitive theory and the social eco-
logical theory [50], the self-efficacy and self-management
theories [55] and the cognitive theory and operant re-
inforcement theory [56]. One study stated that the
DSME was 'participatory' [42].
The number of participants in each group was re-
ported in ten studies [32,33,36,38,39,43,46,50-54,56]. The
smallest group comprised five to eight participants [32]
and the largest group comprised 40 patients per ses-
sion [50].
In one study [56], both the intervention and the con-
trol groups attended a 4-week education programme be-
fore randomisation. The intervention group was then
given additional 15 hours of education (1.5 hour monthly
for 10 months).
The control groups were placed on waiting lists to re-
ceive the DSME after the study in four studies
[34,37,48,55]. In sixteen studies, the comparison group
received routine treatment [32,33,36,38-47,49-54,56]. It
was not clear what type of routine treatment was offered
to the control group participants in one study [35]. Rou-
tine treatment was defined differently among the studies;
as twice-a-year appointments with the physicians and
diabetes specialist nurses for biomedical tests and exami-
nations in accordance with regional diabetes guidelines
based on the Swedish National Guidelines [32], separate
one-hour-long individual appointments with a dietician,
practice nurse and general practitioner [38], one or two
visits per year with the respective diabetes nurses [41]N participants (Int/contr) Diff (95%CI) P-value
1029/983 0.92 (0.76 to 1.10) 0.355
1204/1128 -0.02 (-0.96 to 0.92) 0.967
1152/1081 0.09 (-0.39 to 0.57) 0.712
1006/913 -0.18 (-0.98 to 0.63) 0.670
1370/1276 0.09 (-0.05 to 0.23) 0.213
748/691 0.91 (0.68 to 1.23) 0.553
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scheduled medical follow up visits, which consisted of
verbal information and one or two pamphlets on self-
management skills [43]. It also involved one individual
session by a study nutritionist at the beginning of the
study [44], usual care with three brochures from Ameri-
can Diabetes Association [45], 15 to 20 minutes with a
multidisciplinary diabetes team every three months ap-
proach [51-54] or an individual appointment with a diet-
ician every three months [56].
Twelve publications had some sections of their
results recalculated before input into the meta-analysis
[34-37,39,40,42,44,45,48,49,54]. Two studies [34,35] re-
ported their fasting blood glucose results in mg/dl. For
inclusion in the meta-analysis, these were converted to
mmol/l. One study [36] did not report the standard
deviations with the findings while another [37] did not
report the standard deviation for the treatment satisfac-
tion results. One study [39] reported the results as means
with the standard error of the mean and another [40]
presented some outcomes without standard deviations
and reported p-values without presenting the actual data.
One study [48] presented results in form of graphs with
means and confidence intervals and another [42] reported
some outcomes with means and confidence intervals and
others with means and standard deviations. One study
[47] reported the findings as mean changes from baseline
with standard deviations and another [44] also reported
the findings as mean changes from baseline but did not
give standard deviations. Five studies [44,45,47,49,54]
reported their lipid profile findings in mg/dl and these
were converted to mmol/l for analysis.
All trials included in the review except two [33,35],
assessed glycated haemoglobin (HbA1c) at some time
point.
The studies that recorded the number of deaths did
not identify whether or not the deaths were diabetes
related. Only one study recorded diabetes complications
(creatinine, albuminuria, diabetic retinopathy, foot ulcers)
at two years [52] and four years [53].
General quality of life was assessed using Average
quality of life questionnaire [38,58]; SF 12 Mental and
physical health [49] and SF 36 Thai version [55]. Disease
specific quality of life was measured using the Audit of
diabetes dependent quality of life [38,47]; Diabetes Dis-
tress Scale [50]; Diabetes Quality of Life [54]; Problem
Areas in Diabetes (PAID) Social and Self-care [49] and
Diabetes Symptom Checklist (DSC-R) [41].
Diabetes knowledge was assessed using General know-
ledge of diabetes questionnaire [43,46]; Confidence in
diabetes knowledge scale [32]; Knowledge, Attitudes and
Practices scores [33]; Lifestyle measure [38]; Diabetes
knowledge [45]; Audit of diabetes knowledge scale [47]
and Knowledge of diabetes questionnaire [54].Diabetes self-management skills were assessed using
Self-care activities and food frequency questionnaire
[37,38,46]; Health behaviour conduct and Problem solv-
ing ability [51-54]; Self-monitoring of blood glucose
levels [42,47] and Stages of change questionnaire [40].
Self-efficacy/empowerment was assessed using Self
efficacy-plate model [32]; Diabetes empowerment scale
[38,45]; Self efficacy scores for diet, exercise, self-
monitoring, oral glycaemic agents, insulin [47]; Confi-
dence to overcome challenges [50] and Sallies self-efficacy
for diet and exercise [50].
Satisfaction with treatment was assessed using Satisfac-
tion with daily life [32]; Patient treatment satisfaction
[36]; Diabetes treatment satisfaction questionnaire [38,41]
and Personal models of disease questionnaire [37].
A cost-effectiveness analysis was performed at a four
year follow-up for one study [53] and the cost of deliver-
ing the programme was estimated in two studies [34,50].
Ten studies presented a power calculation and based
recruitment numbers on the calculation [32,36-38,42-
44,48,50,55] and all of these managed to reach their tar-
get sample sizes.
Risk of bias
Based on the quality criteria described in the methods
section, two studies were classified as having a low risk
of bias [32,38], 12 studies as having moderate risk of bias
[33,36,37,39-42,45,48-55], and seven studies were classi-
fied as having a high risk of bias [34,35,43,44,46,47,56].
The methods of sequence generation were elaborated
in five studies [33,36,38,48,51-54]. One study stated that
the sequence generation was conducted using permuted
random blocks [38], while another used identical envel-
opes containing participants details put in a box and
randomly assigned to intervention or control group [48].
The Trento study used random number tables for se-
quence generation [51-54]. One study stated that mini-
mization was performed [33] and another stated that the
sequence generation was computerised [36]. Eleven
studies did not provide the details of how sequence gen-
eration was conducted, although they made reference to
it by stating that participants were randomly allocated to
either interventionorcontrolgroups [34,35,37,39,40,42,44-
47,56]. In five studies [32,41,43,49,50,55], the methods of
sequence generation were not mentioned.
Allocation concealment was done using sealed opaque
envelopes in three studies [32,38,48]. In one study [41],
randomisation was done at clinic level, to allocate clinics
to the intervention group and to the control group, im-
plying that most probably there was no allocation con-
cealment. In another study [37], it was mentioned that
participants were blindly and randomly allocated, imply-
ing that most probably allocation concealment was done.
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cealment in their reports [33-36,39,40,42-47,49,50,55,56].
Only one study made reference to attempts made to-
wards blinding of treatment [38]. The study attempted
to blind the control group to the fact that they were the
controls by presenting 'routine treatment' as an individ-
ual appointment intervention. Trento [52,53] reported
that the physicians who were in charge of group sessions
also attended to the control participants during the gen-
eral diabetes clinics, but were blinded to the control par-
ticipants’ status in the study to avoid performance bias.
Only one study [38] reported that outcome assessment
was performed by a community nurse and health care as-
sistant, who were both blinded to treatment assignment.
Thirteen studies were considered not to have any in-
complete outcome data reported. Ten of these ensured
that data of participants that dropped-out from the stud-
ies before the end were reflected in the analysis
[32,36,39,41-43,45,46,48,55]. Eight stated that their ana-
lyses were by intention to treat [38,40,49-54]. Two stud-
ies had some incomplete outcome data [33,34]. One of
the studies [33] stated that the study lost 15 (25 %) out
of 59 intervention participants and 23 (39 %) out of 59
control participants at 6 months follow up. However,
intention to treat analysis was not stated and the data
for the participants that dropped-out was not included
in the outcome tables. The other study [34] also did not
mention that intention to treat analysis was conducted
and did not show the numbers of participants included
in the analysis to give an indication whether the ones
who dropped-out were included in the analysis or not.
For the remaining six studies, it was unclear whether the
issue of incomplete outcome data was sorted out or not.
Five studies [35,37,44,47,56] did not indicate whether
their studies had lost some participants to follow-up and
neither did they mention that intention to treat analyses
were conducted.
All the studies measured and reported all the pre-
specified outcomes except for two studies [36,44]. One
of the studies [36] did not report on glycated haemoglo-
bin at six months, and blood pressure and lipid profiles
at six and 12 months, and the other [44] only reported
weight change at 12 months follow-up, and did not re-
port on the other outcomes at 12 months follow up
(HbA1c, BMI, Cholesterol level, Blood pressure).
Quality assessment of most of the studies led to the con-
clusion that there was possibility for bias due to missing
information and unclear issues. However, for five studies
[32,38,41,42,48], there were no further issues of concern
identified that could be deemed possible causes of bias.
Effects – main outcomes
Thirteen studies [34,37-40,43-49,55] involving 1827 par-
ticipants assessed glycated haemoglobin (HbA1c) at sixmonths. The mean difference was -0.44 percentage
points (95% CI: -0.69 to -0.19, P = 0.0006, Table 3: Ana-
lysis 3.1) in favour of DSME with a heterogeneity of
I2 = 56%. At the 12 months' follow-up, the meta-analysis
of 11 studies [32,34,36-39,41,42,48,51,56] including 1503
participants gave a mean absolute difference of -0.46
percentage points (95% CI: -0.74 to -0.18, P = 0.001,
Table 3: Analysis 3.2) with a heterogeneity of I2 = 65%.
The heterogeneity was due to two outlying studies
[37,41] which reported the highest reduction in HbA1c
in favour of the DSME of 1.0 percentage points [41]
and the highest increase of 0.7 percentage points [37].
Removing these, the nine remaining studies showed an
overall significant reduction in HbA1c of -0.50 percent-
age points (95% CI: -0.73 to -0.27, P< 0.0001, I2 = 33%).
Using changes in HbA1c from baseline to twelve months
for all the 11 studies, gave a change in HbA1c in favour
of DSME of -0.55 percentage points (95% CI: -0.75 to
-0.35, P< 0.00001, I2 = 37%), thus reflecting the slight
non-significant difference in baseline values between
the groups (Table 2: Analysis 1.5). Three studies in-
volving 397 patients assessed glycated haemoglobin at
two years [42,48,52] with no heterogeneity between the
studies (I2 = 0%). There was a significant reduction in
HbA1c for the patients allocated to the DSME com-
pared to the control group (-0.87 percentage points;
95% CI: -1.25 to -0.49, P< 0.00001, Table 3: Analysis
3.3).The Trento study also assessed glycated haemoglo-
bin at four [53] and five [54] years' follow-up. The
four year follow-up involved 90 patients and found a
significant reduction in the group education group
compared to the control group (-1.6 percentage points;
95% CI: -2.3 to 0.9, P< 0.00001). The five year follow-up
involved 112 participants and reported reduction of
1.7 percentage points in the intervention group com-
pared to the control group (95% CI: -2.19 to -1.21,
P = 0.00001).
Three studies [34,45,46] with a total of 401 partici-
pants reported on fasting blood glucose levels at six
months. With all the studies included, the heterogeneity
was I2 = 68% and the mean difference was -0.73 mmol/l
(95% CI: -2.22 to 0.76, P = 0.34, Table 3: Analysis 3.4).
However, removing one study [46] reduced the hetero-
geneity to I2 = 0% and a mean difference in favour of the
DSME of -1.53 mmol/l (95% CI: -2.37 to -0.69,
P = 0.0004) was observed. The baseline difference be-
tween the groups in the removed study [46] were 0.42
and although this increased to 0.66 at eight months, the
difference between this study and the other two became
larger (and thereby increasing heterogeneity) due to the
difference in baseline value. Thus, due to the problem of
heterogeneity, no conclusion can readily be drawn about
the result of fasting blood glucose at 6 months. At
12 months, five studies assessed fasting blood glucose
Table 3 Meta-analysis of primary and secondary outcomes of group-based diabetes self-management education
programme with comparison for intervention (Int) and control (contr) groups and the heterogeneity (measured by I2)
of the analyses
Analysis number / Outcome Effect
measure
N studies N participants
(Int/contr)
Difference
(95%CI)
P-valueA Hetero-geneity
(I2)
3.1 Glycated haemoglobin (6 months) Mean Diff 13 977/850 -0.44 (-0.69 to -0.19) 0.001 55.8
3.2 Glycated haemoglobin (12 months) Mean Diff 11 750/753 -0.46 (-0.74 to -0.18) 0.001 64.6
3.3 Glycated haemoglobin (2 years) Mean Diff 3 199/198 -0.87 (-1.25 to -0.49) 0.000 0.0
3.4 Fasting blood glucose (6 months) Mean Diff 3 206/195 -0.73 (-2.22 to 0.76) 0.336 68.1
3.5 Fasting blood glucose (12 months) Mean Diff 5 344/346 -1.26 (-1.69 to -0.83) 0.000 0.0
3.6 Diabetes knowledge (6 months) Std Mean Diff 6 390/378 0.69 (0.43 to 0.96) 0.000 63.5
3.7 Diabetes knowledge (12 months) Std Mean Diff 5 477/478 0.85 (0.48 to 1.22) 0.000 85.5
3.8 Self management skills (6 months) Std Mean Diff 4 295/239 0.55 (0.11 to 0.99) 0.015 79.1
3.9 Quality of life (6 months) Std Mean Diff 3 242/231 0.31 (-0.15 to 0.78) 0.186 77.1
3.10 Self efficacy/Empowerment (6 months) Std Mean Diff 2 167/159 0.28 (0.06 to 0.50) 0.012 0.0
3.11 Weight (6 months) Mean Diff 3 216/217 -2.08 (-5.55 to 1.39) 0.239 48.2
3.12 Body Mass Index (6 months) Mean Diff 7 633/526 -0.21 (-0.86 to 0.43) 0.514 0.0
3.13 Weight (12 months) Mean Diff 4 247/245 -1.66 (-3.07 to -0.25) 0.021 0.0
3.14 Body Mass Index (12 months) Mean Diff 7 538/554 -0.22 (-1.13 to 0.69) 0.634 62.2
3.15 Systolic blood pressure (6 months) Mean Diff 5 454/360 -0.34 (-5.19 to 4.51) 0.891 67.9
3.16 Diastolic blood pressure (6 months) Mean Diff 5 454/360 -0.46 (-2.31 to 1.39) 0.627 26.6
3.17 Systolic blood pressure (12 months) Mean Diff 2 168/159 -2.61 (-6.74 to 1.52) 0.216 0.0
3.18 Total cholesterol (6 months) Mean Diff 7 632/529 -0.04 (-0.17 to 0.10) 0.605 0.0
3.19 Triglycerides (6 months) Mean Diff 7 632/529 -0.16 (-0.35 to 0.03) 0.104 0.0
3.20 Total cholesterol (12 months) Mean Diff 4 324/332 0.07 (-0.09 to 0.24) 0.377 0.0
3.21 Triglycerides (12 months) Mean Diff 4 325/332 0.03 (-0.42 to 0.48) 0.883 79.7
3.22 High density lipoprotein (6 months) Mean Diff 6 515/417 0.02 (-0.05 to 0.08) 0.623 0.0
3.23 Low density lipoprotein (6 months) Mean Diff 6 515/417 -0.05 (-0.20 to 0.10) 0.528 0.0
3.24 Treatment satisfaction (6 months) Std Mean Diff 2 205/185 0.65 (0.44 to 0.85) 0.000 0.0
3.25 Treatment satisfaction (12 months) Std Mean Diff 3 247/237 0.39 (0.21 to 0.57) 0.000 0.0
3.26 Death Odds Ratio 4 351/349 1.10 (0.37 to 3.29) 0.867 3.2
A. The P- value is calculated for the difference between the intervention and control group.
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(I2 = 0%). There was an overall significant improvement
in patients allocated to the DSME compared with those
in the control group (-1.26 mmol/l; 95% CI: -1.69 to -0.83,
P< 0.00001, Table 3: Analysis 3.5). Two studies assessed
fasting blood glucose at two years [42,52]. The larger
of the two studies [42] involving 243 participants
showed a significant improvement of fasting blood glu-
cose in favour of the DSME (difference 1.8 mmol/l; 95% CI:
1.2 to 2.4, P< 0.00001) but the other study [52] involving
80 participants did not show a significant improvement in
the DSME over the control group (difference 0.7 mmol/l;
95% CI: -0.4 to 1.9, P=0.24). However, the Trento study
reported a significant difference between groups at the four
years' follow-up [53] in favour of the DSME (difference
1.7 mmol/L; 95% CI: 0.2 to 3.2, P=0.03), while thedifference between the groups at the five year follow-up
[54] was not significant (-0.10%, 95% CI: -1.18 to 0.98,
P=0.86).
Six studies with a combined total of 768 participants mea-
sured diabetes knowledge at six months [33,38,43,45-47]. As
the studies had used different validated questionnaires to
measure knowledge, the standardised mean difference
method of analysis was used. Heterogeneity between the
studies was I2=64% (SMD 0.69; 95% CI: 0.43 to 0.96,
P< 0.00001, Table 3: Analysis 3.6). When one study [33],
which reported the least increase in knowledge among the
intervention group was removed, the heterogeneity was
removed (I2=0 %) giving a SMD of 0.83 (95% CI: 0.67 to
0.99, P< 0.00001). At 12 months five studies involv-
ing 955 participants measured diabetes knowledge
[34,38,39,42,51]. However, there was significant
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1.22, P< 0.00001, I2 = 85%, Table 3: Analysis 3.7).
Three studies had to be removed to reduce the hetero-
geneity [34,38,39], two large ones with lower SMD and
one smaller with higher SMD. The meta-analysis with
the remaining two studies [42,51] with a combined
total of 333 participants gave a SMD of 1.03 (95% CI:
0.8 to 1.26, P< 0.00001, I2 = 0%). Two studies mea-
sured diabetes knowledge at two years. There was, sig-
nificant heterogeneity (I2 = 97%) and a meta-analysis
was not performed. Both studies showed significant
better knowledge for the intervention group [42]: SMD
2.31; 95% CI: 1.99 to 2.64, P< 0.00001; [52]: SMD 0.86;
95% CI: 0.47 to 1.24, P = 0.0001). At four and five years
follow up, Trento [53,54] measured diabetes know-
ledge and found that increased diabetes knowledge
remained in the patients allocated to the DSME [53]: SMD
1.27; 95% CI:0.82 to 1.73, P< 0.00001; [54]: SMD 1.36;
95% CI: 0.95 to 1.77, P = 0.00001).
Seven studies measured some aspect of self-
management [38,40,42,46,47,49,51-54]. However, only
four studies involving 534 participants had data that
could be used in a meta-analysis using standardised
mean difference at six months [38,46,47,49]: SMD 0.55
(95% CI: 0.11 to 0.99, P = 0.01, I2 = 79%, Table 3: Analysis
3.8. Removing one study [47], which had the highest ef-
fect size, eliminated the heterogeneity (I2 = 0%) and
resulted in a SMD of 0.29 (95% CI: 0.11 to 0.46,
P = 0.002). One study [38] reported that at 14 months,
self-management scores had remained significant in re-
spect of exercise (P = 0.02) and foot care (P = 0.003) but
there was no significant difference between the groups
for self-monitoring of blood glucose levels (P = 0.17). For
food intake, there were trends suggesting that the parti-
cipants invited to the group intervention compared to
those in the control group were consuming more per-
centage energy from carbohydrate (difference 3.3%; 95%
CI: 0.3 to 6.9, P = 0.07), more energy from total sugars
(difference 6.6%; 95% CI: 3.4 to 9.9, P< 0.001), less en-
ergy from total fat (difference 2.7%; 95% CI: 0.3 to 5.6,
P = 0.08), less energy from saturated fat (difference 1.1%;
95% CI: 0.0 to 2.3, P = 0.05) and an extra 2 portions of
fruit and vegetables per day (difference 2.2 portions; 95%
CI: 1.1 portions to 3.2 portions, P< 0.001). The other
three studies not included in the analysis provided narra-
tive reports of their findings on self-management. One
study [42] measured the percentage of participants who
carried out self-monitoring of blood glucose levels and
found a significant difference between the two groups in
favour of the DSME at both one and two
years (P< 0.005). The second study [40] reported that the
group programme participants made positive improvement
in stages of change for five behaviours: physical activity
(P=0.003); reduction of high fat foods (P=0.008);consumption of five portions of fruit and vegetables
(P< 0.0001); consumption of three meals daily (P=0.09);
limitation of refined sugar intake to one product per day or
less (P=0.001). However, the statistical analysis was per-
formed on pre-test means versus post-test means for the
intervention group and no data was provided for the
control group. Trento developed and validated a
health behaviours questionnaire and reported that
the score was significantly greater for the group edu-
cation participants than for the controls at one year
([51], P< 0.005), two years ([52], P< 0.001), four years
([53], P< 0.001) and five years ([54], P< 0.00001).
Three studies with 473 participants measured quality
of life at six months [38,47,55]) using different question-
naires. Heterogeneity between the studies was high with
no differences between the groups (SMD 0.31; 95 % CI:
-0.15 to 0.78, P = 0.19, I2 = 77%, Table 3: Analysis 3.9).
The heterogeneity was due to one study [38] and remov-
ing this study removed heterogeneity and gave a signifi-
cant SMD of 0.57 (95% CI: 0.27 to 0.88, P = 0.0003, 172
participants). The removed study [38] found no overall
improvement in overall quality of life but in the sub-
scales there were significant improvement for the DSME:
freedom to eat (difference 1.7; 95% CI: 0.8 to 2.5,
P< 0.001); enjoyment of food (difference 1.2; 95% CI:
0.2 to 2.1, P = 0.046); and freedom to drink (difference
1.5; 95% CI: 0.4 to 2.5, P = 0.005). Thus, due to the
problem of heterogeneity, no conclusion can readily be
drawn about the result of overall quality of life at
6 months. At 12 months two studies measured quality
of life [38,51]. The first study [38] reported similar
results to those at four months, namely no significant
improvement in overall quality of life, but significant
improvements for the sub-scales: freedom to eat (differ-
ence 1.1; 95% CI: 0.2 to 2.1, P = 0.04); enjoyment of food
(difference 1.1; 95% CI: 0.1 to 2.0, P = 0.05); and free-
dom to drink (difference 1.5; 95% CI: 0.5 to 2.6,
P = 0.01). The second study [51] did not find a signifi-
cant difference in quality of life at 12 months but
reported a significant improvement in quality of life at
two years ([52], P< 0.001), at four years ([53], P< 0.009)
and at five years ([54], P< 0.00001).
Two studies [38,47], with a total of 326 participants
assessed the level of empowerment and psychosocial
self-efficacy at six months. As the studies had used dif-
ferent questionnaires the standardised mean difference
(SMD) was used. There was no heterogeneity between
the studies (I2 = 0%), and improvement in self-efficacy
among the intervention groups was 0.28 above that of
the control groups (95% CI: 0.06 to 0.50, P = 0.01,
Table 3: Analysis 3.10). Only [38] assessed empower-
ment scores at 12 months, and the scores were still sig-
nificantly higher amongst patients allocated to the
DSME: the total empowerment (difference 0.3; 95% CI:
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betes (difference 0.3; 95% CI: 0.02 to 0.7, P = 0.005);
readiness to change (difference 0.3; 95% CI: 0.1 to 0.5,
P = 0.001); and setting and achieving goals (difference
0.2; 95% CI: 0.05 to 0.4, P = 0.02).
Effects – secondary outcomes
Three studies, having a combined total of 433 partici-
pants, assessed body weight at six months [38,39,45].
The heterogeneity for the three studies was I2 = 48%.
Overall reduction in body weight was 2.08 kg more than
in the control group but the difference was not statisti-
cally significant (95% CI: -5.55 to 1.39, P = 0.24, Table 3:
Analysis 3.11). Seven studies involving 1159 participants
assessed BMI at six months [34,38,44-47,49] with no
heterogeneity between studies (I2 = 0%). There was a dif-
ference between groups of 0.21 kg/m2 in favour of group
education but, as in the case of body weight, that differ-
ence was not statistically significant (95% CI: -0.86 to
0.43, P = 0.51, Table 3: Analysis 3.12). At 12 months four
studies, involving 492 patients, assessed body weight
[38,39,51,56] with no heterogeneity between studies
(I2 = 0%). The mean difference between the DSME and
control group was 1.66 kg (95% CI: -3.07 to -0.25,
P = 0.02, Table 3: Analysis 3.13). Also at 12 months,
seven studies with a total of 1092 participants assessed
BMI [32,34,35,38,41,42,51] with a heterogeneity of
I2 = 62%. There were no significant difference between
the groups (-0.22 kg/m2; 95% CI: -1.13 to 0.69, P = 0.63,
Table 3: Analysis 3.14). Heterogeneity was caused by one
study [35] but removing this did not change the results
(0.12 kg/m2 (-0.67, 0.91), P = 0.76, I2 = 35%). One study
[38] measured waist circumference at both four and
14 months. There was no significant difference between
the two groups at four months (difference 1.3 cm; 95%
CI: -1.8 to 4.1, P = 0.44) but there was a trend in favour
of the DSME at 14 months (difference 2.8 cm; 95% CI:
-0.3 to 5.6, P = 0.06).
Five studies including 814 participants measured sys-
tolic and diastolic blood pressure at six months
[38,44,45,47,49] Heterogeneity between the studies for
systolic blood pressure was I2 = 68% with no significant
difference from baseline (-0.34 mmHg, 95% CI: -5.19 to
4.51, P = 0.89, Table 3: Analysis 3.15). The heterogeneity
was due to one study [38], but removing this study did
not change the non-significant results (1.76 mmHg; 95%
CI: -2.61 to 6.13, P = 0.43, I2 = 42%). Neither was the dia-
stolic blood pressure influenced by the DSME
(-0.46 mmHg; 95% CI: -2.31 to 1.39, P = 0.63, I2 = 27%,
Table 3: Analysis 3.16). At 12 months, two studies mea-
sured blood pressure [38,56]). There was no heterogen-
eity between the studies for systolic blood pressure
(I2 = 0%). Although there was a small reduction in re-
spect of systolic blood pressure, it was not statisticallysignificant (3 mmHg; 95% CI: -7 to 2, P = 0.22, Table 3:
Analysis 3.17). For diastolic BP, there was substantial
heterogeneity of I2 = 70% (0.17; 95% CI: -4.46 to 4.80,
P = 0.94). Neither of the two studies reported a signifi-
cant difference between the intervention group and con-
trol group for diastolic blood pressure.
Seven studies including 1161 participants assessed
total cholesterol and triglycerides at six months
[34,38,44-47,49] with no significant differences (Total
cholesterol -0.06 mmol/l; 95% CI: -0.23 to 0.12, P = 0.54,
I2 = 4%,Table 3: Analysis 3.18; Triglycerides: -0.05 mmol/l;
95% CI: -0.19 to 0.08, P = 0.45, I2 = 37%, Table 3: Analysis
3.19). At 12 months, four studies [34,38,41,56] involving
657 patients displayed no statistically significant differ-
ences between groups (0.07 mmol/l, 95% CI: -0.09 to
0.24, P = 0.38, I2 = 0%, Table 3: Analysis 3.20) for total
cholesterol. With regard to triglyceride levels, heterogen-
eity was high (I2 = 80%), though there were no differ-
ences between the groups (0.03 mmol/l, 95% CI: -0.42 to
0.48, P = 0.88, Table 3: Analysis 3.21). The high hetero-
geneity was caused by one study [41] which was the only
study that reported a reduction in triglyceride levels in
intervention group at 12 months (-0.52 mmol/l, 95% CI:
-0.82 to -0.22, P = 0.0006). When this study [41] was re-
moved from the meta-analysis, the heterogeneity among
the remaining three studies reduced to 0% but still there
were no statistically significant differences (0.16 mmol/l,
95% CI: -0.06 to 0.39, P = 0.15, Table 3: Analysis 3.21).
High density lipoproteins (HDL) and low density lipopro-
teins (LDL) were assessed at six months by six studies
[38,44-47,49] with a total of 932 participants. HDL ana-
lysis revealed no heterogeneity among the groups
(I2 = 0%) and also a non-significant decrease in the HDL
(-0.01 mmol/l, 95% CI: -0.05 to 0.03, P = 0.75, Table 3:
Analysis 3.22) among the intervention group. LDL ana-
lysis also showed a non-significant reduction in the inter-
vention group (-0.05 mmol/l, 95% CI: -0.2 to 0.1,
P = 0.54, I2 = 37%, Table 3: Analysis 3.23).
Two studies [37,38] with 390 participants measured
change in treatment satisfaction at six months. There
was no heterogeneity between the studies (I2 = 0%), and
they found that the group education participants were
significantly more satisfied with their treatment (SMD
0.65; 95% CI: 0.44 to 0.85, P< 0.00001, Table 3: Analysis
3.24). At 12 months, three studies including 484 partici-
pants reported on treatment satisfaction [37,38,41]. The
intervention group was significantly more satisfied with
their treatment than the control group (SMD 0.39; 95% CI:
0.21 to 0.57 P< 0.0001, I2 = 0%, Table 3: Analysis 3.25).
At the 12 month outcome assessment there had been
a total of 17 deaths reported from four studies with a
combined total of 700 participants [32,36,38,51]. There
was low heterogeneity (I2 = 3%). One study reported
more deaths in the control group [38], whereas two
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[36,51]. One study [32] had the same number of deaths
in the intervention group as in the control group. Over-
all there were nine deaths in the intervention group and
eight deaths in the control group. At the five year
follow-up, the Trento study [54] also reported three
deaths in the intervention and five in the control group
respectively. Participation in a DSME, therefore, was not
shown to affect mortality rate (odds ratio 1.1, 95% CI:
0.37 to 3.29, P = 0.87, Table 3: Analysis 3.26).
Only one study [38] reported the changes in medication
at the 14 months follow-up period. Twenty-four (16%)
reduced medication in the intervention group compared to
one (0.7%) in the control group. Ninety-five (63%) interven-
tion group patients and 75 (53%) control group patients
remained on the same dose. Thirty-one (21%) intervention
group patients and 65 (46%) control group patients
increased their diabetes medication. The study concluded
that for every seven patients who participated in the
programme, one patient could be expected to have reduced
their diabetes medication by 14 months (95% CI: 5 to 11,
p< 0.0001).
Two studies reported cost but did not carry out cost ef-
fectiveness analysis [34,50]. The first study [34] reported
that the cost of providing the intervention (52 contact
hours over 12 months) was US $384 per person and the
second study [50] reported that the total direct and indirect
costs of providing the intervention were US $2,510 per par-
ticipant for the 24 months period. One study did a cost ef-
fectiveness analysis [53]. It was found that over the study
period group care required 196 minutes and US $756.54
per patient, compared with 150 minutes and US $665.77
for the control patients. It was reported that an additional
US $2.12 was spent per point gained in the quality of life
score.
Only one study monitored the presence of diabetes
complications and it reported no significant differ-
ences between the group education participants and
controls in respect of diabetic retinopathy and foot
ulcers at two years [52] but found that at four years
follow-up [53], diabetic retinopathy had progressed
more slowly amongst participants that had attended
the DSME (P< 0.009). No adverse effects were
reported for the group education participants or the
controls.Subgroup analyses
Subgroup analyses were done on the studies that had
12 months data on glycated haemoglobin (Table 4). Due to
heterogeneity the changes from baseline to 12 months was
used, giving a difference of glycated haemoglobin at
12 months of -0.55 percentage points (95%CI: -0.75 to -0
.35, P< 0.00001, I2= 37%).Limiting the analysis to studies with 8 hours or less of
education provided resulted in little or no change in the
main outcome (-0.55) [39,42,51].
Studies with mainly a non-Caucasian sample [34,36],
reporting theoretical model (-0.43) [32,37,38,51,56], using
a combination of different types of educators to deliver
the intervention [32,34,36,39,48,51], baseline haemoglo-
bin levels of 7% or higher (-0.45) [32,34,36-39,51,56], that
included follow up (-0.14) [32,39], completed delivery of
their education programmes in 12 months (-0.35)
[34,36,48,51], provided 9 to 12 hours of education (-0.39)
[32,38,48], had a family member or friend was invited to
attend as participants (-0.41) [34,39,51] or had less than
6 (-0.52) [32,39,42,51] or more than 10 sessions (-0.42)
[34,36,48] had less effect of the intervention than all the
studies together.
Studies using diabetes specialist nurses as the only type
of educator (-0.72) [37,41,42], dieticians only as educa-
tors (-0.80) [38,56], conducted in primary care settings
(-0.61) [32,34,36,38,41,42], intervention lasting from one
to five months (-0.65) [37-39,42] or 6 to 10 months
(-0.69) [32,41,56], provided 19 to 52 hours of education
(-0.73) [34,36,41], between 14 and 18 participants per
group session (-0.67) [36,38,56] or between 6 and 10 ses-
sions (-0.76) [37,38,41,56] had better effect of the inter-
vention than all the studies together.
Sensitivity analyses
The sensitivity analyses were also performed on the sub-
sets of studies glycated haemoglobin at 12 months
(Table 5). Only two studies were assessed as having low
risk of bias [32,38] and these produced a non-significant
effect (-0.42 percentage points, 95% CI: -1.00 to 0.17,
P = 0.16, I2 = 77%, Table 5: Analysis 5.4). The seven stud-
ies with moderate risk of bias [36,37,39,41,42,48,51] gave
a statistically significant difference of -0.55 percentage
points (95% CI: -0.79 to -0.31, P< 0.00001, I2 = 30%,
Table 5: Analysis 5.5). Two studies with high risk of bias
[34,56] produced no heterogeneity (I2 = 0%) and a sig-
nificantly high effect of -0.95 percentage points (95% CI:
-1.55 to -0.35, P = 0.002, Table 5: Analysis 5.6). An ana-
lysis of the two low risk and seven moderate risk studies,
gave a difference of -0.51 percentage points (95% CI: -0.72
to -0.29, P< 0.00001, I2= 41%, Table 5: Analysis 5.7).
These results indicate that despite having greater interven-
tion effects, the high risk of bias studies did not influence
the overall result substantially.
The studies that had some of their results recalculated
to make them suitable for entering in a meta-analysis
(-0.54) [34,36,37,39,42,48] had similar effect to the overall
analysis. The studies that which had each a total number
of participants more than the identified median of 104
participants (-0.67) [34,36,38,41,42,51] or dropout rates of
less than 10% (-0.79) [34,38,41,42,56] had better effect.
Table 4 Sub group analysis of the studies that had 12 months data on glycated haemoglobin (changes from baseline
to 12 months) with comparison for intervention (Int) and control (contr) groups and the heterogeneity (measured by
I2) of the analyses
Analysis number / Outcome Effect
measure
N studies N participants
(Int/contr)
Difference
(95%CI)
P-valueA Heterogeneity
(I2)
4.1 Ethnicity (Most non-Caucasian) Mean Diff 2 208/202 -0.49 (-0.97 to -0.01) 0.046 0.0
4.2 Theoretical model stated: Mean Diff 4 309/291 -0.43 (-0.79 to -0.08) 0.017 52.1
4.3 Educator stated: Diabetes
specialist nurse only
Mean Diff 3 217/219 -0.72 (-1.01 to -0.43) 0.000 35.8
4.4 Educator stated: Dietician only Mean Diff 2 168/159 -0.80 (-1.22 to -0.37) 0.000 15.2
4.5 Educator stated: Studies with
more than 1 instructor
Mean Diff 6 365/375 -0.27 (-0.53 to -0.02) 0.038 0.0
4.6 Delivered as Primary care
intervention
Mean Diff 6 564/572 -0.61 (-0.85 to -0.37) 0.000 48.6
4.7 Both groups glycated
haemoglobin 7 % & above
at baseline
Mean Diff 8 553/532 -0.45 (-0.69 to -0.20) 0.000 24.1
4.8 Studies with follow-up
sessions/phone
calls before 12 months
Mean Diff 2 78/85 -0.14 (-0.56 to 0.27) 0.500 0.0
4.9 Studies with follow-up
sessions/phone
calls after 12 months
Mean Diff 2 153/161 -0.61 (-0.95 to -0.27) 0.000 10.7
4.10 Delivery of education programme
completed in 1-5 months
Mean Diff 4 359/339 -0.65 (-0.87 to -0.42) 0.000 0.0
4.11 Delivery of education programme
completed in 6-10 months
Mean Diff 3 104/124 -0.69 (-1.34 to -0.03) 0.040 79.7
4.12 Delivery of education programme
completed in 12 months
Mean Diff 4 287/290 -0.35 (-0.67 to -0.02) 0.035 0.0
4.13 First quartile hours of education
programme (8 hours or less)
Mean Diff 3 202/212 -0.55 (-0.86 to -0.23) 0.001 11.2
4.14 Second quartile hours of education
programme (9 to 12 hours)
Mean Diff 3 225/225 -0.39 (-0.81 to 0.03) 0.068 57.4
4.15 Third quartile hours of education
programme (13 to 18 hours)
Mean Diff 2 71/54 -0.69 (-1.74 to 0.37) 0.201 66.2
4.16 Fourth quartile hours of education
programme (19 to 52 hours)
Mean Diff 3 252/262 -0.73 (-1.08 to -0.38) 0.000 27.8
4.17 Attendance rate less than 70 % Mean Diff 3 132/124 -0.22 (-0.60 to 0.15) 0.243 0.0
4.18 Number of participants in each
group session between 5 & 10
Mean Diff 3 124/135 -0.17 (-0.50 to 0.16) 0.321 0.0
4.19 Number of participants in each
group session between 14 & 18
Mean Diff 3 264/249 -0.67 (-1.06 to -0.27) 0.001 28.8
4.20 Family & friends included in
group sessions
Mean Diff 3 194/201 -0.41 (-0.83 to 0.01) 0.053 0.0
4.21 Number of sessions (5 or less) Mean Diff 4 244/258 -0.52 (-0.75 to -0.28) 0.000 0.0
4.22 Number of sessions (6 to 10) Mean Diff 4 265/255 -0.76 (-1.04 to -0.48) 0.000 28.0
4.23 Number of sessions (11 or more) Mean Diff 3 241/240 -0.42 (-0.82 to -0.02) 0.040 0.0
A. The P- value is calculated for the difference between the intervention and control group.
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In total 21 studies (26 publications, 2833 participants) of
group-based, diabetes self-management education pro-
grammes for people with type 2 diabetes were included.
It was found that these programme overall resulted in sig-
nificant health outcomes like improved glycaemic controland increased diabetes knowledge, self-management skills
and self-efficacy/empowerment.
Limitations
As a large number of outcomes and subgroups have
been analysed, there is a possibility of type II error. The
Table 5 Sensitivity analysis of the studies that had 12 months data on glycated haemoglobin (changes from baseline
to 12 months) with comparison for intervention (Int) and control (contr) groups and the heterogeneity (measured by
I2) of the analyses
Analysis number / Outcome Effect
measure
N studies N participants
(Int/contr)
Difference
(95%CI)
P-valueA Heterogeneity
(I2)
5.1 Non-translated publications Mean Diff 10 630/630 -0.52 (-0.75 to -0.28) 0.000 41.0
5.2 Number of participants more than
median of all studies with 12 months
HbA1c data(104 total)
Mean Diff 6 568/576 -0.67 (-0.86 to -0.48) 0.000 18.4
5.3 Studies with any part of results
recalculated (HbA1c 12-14 months)
Mean Diff 6 450/438 -0.54 (-0.78 to -0.31) 0.000 0.0
5.4 Study quality (Low risk of
bias):glycated haemoglobin
12-14 months
Mean Diff 2 192/187 -0.42 (-1.00 to 0.17) 0.163 77.4
5.5 Study quality (Moderate risk of bias) Mean Diff 7 428/436 -0.55 (-0.79 to -0.31) 0.000 29.7
5.6 Study quality (High risk of bias) Mean Diff 2 130/130 -0.95 (-1.55 to -0.35) 0.002 0.0
5.7 Study quality (Low & Moderate
risk of bias)
Mean Diff 9 620/623 -0.51 (-0.72 to -0.29) 0.000 41.3
5.8 Drop-out rate less than 10 % Mean Diff 5 444/454 -0.79 (-0.97 to -0.61) 0.000 0.0
A. The P- value is calculated for the difference between the intervention and control group.
Steinsbekk et al. BMC Health Services Research 2012, 12:213 Page 16 of 19
http://www.biomedcentral.com/1472-6963/12/213methodological quality of studies included in the review
was mainly assessed as moderate. However, unlike a
drug/placebo trial, it is very difficult to provide alloca-
tion concealment and to blind the patients and providers
for a group-based educational intervention. Several of
the studies were conducted before analysis by intention-
to-treat became the norm. It was not possible to carry
out a meta-analysis on several of the main outcomes due
to very high heterogeneity between studies, and/or too
few studies reporting on the outcome. The studies were
mostly carried out in different developed countries
throughout Europe and the United States. The results of
this review are therefore likely generalisable to adults
with type 2 diabetes in many different developed coun-
tries and there is no evidence to suggest that group-
based self-management strategies would not be suitable
for developing countries as long as the DSME is deliv-
ered in a familiar language and is sensitive to the culture
of the population.
Although with some variation, the patients included in
the studies were surprisingly similar. They were on aver-
age 60 years old, 40% were male, they were diagnosed
seven years ago, four out of five used medications, and
they had a mean HbA1c level of 8.23%. This indicates
that most participants had a long history of living with
type 2 diabetes. Thus, using the results from this system-
atic review and from most of the single studies included
must be seen in relationship to the characteristics of
those participating. For clinical practice, this indicates
that the current knowledge of the effect of group based
DSME is among a population with a rather long history
of living with type 2 diabetes. It is therefore possible thatthe findings could be different in other populations. Fur-
thermore, as with all clinical trials, it is possible that
patients who participated in the studies may not be truly
representative of the local adult population with type 2
diabetes, as people who volunteer to take part in clinical
trials tend to be a more committed and motivated and
may generally receive more attention when participating
in a clinical trial. Although having motivated participants
will not affect differences between the two groups as
both the intervention and control group are part of the
motivated subgroup, it may affect the generalisability of
the results to DSME’s delivered as routine treatment.
Findings
The meta-analysis of HbA1c at all time points from six
months to five years showed a significant improvement
in the intervention group that received group based
DSME. The same was the case for fasting blood glucose.
The improvement in glycaemic control found in this
study is higher than the effect seen in previous studies
analysing educational and behavioural interventions in
type 2 diabetes [17,27] but lower than the effect seen in
the study comparing the effectiveness of psychological
specialists and general clinicians in the delivery of psy-
chological educational programmes [18]. Furthermore, it
is similar to the first review of group based DSME by
Deakin et.al [28]. In conclusion, it can be said that group
based DSME in general helps improve the participants’
glycaemic control.
There were clear indications in this review that studies
with more numbers of hours of education (19 to 52 hours),
spread over 6 to 10 months or with 6 to 10 sessions tended
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teria have reported that it appeared as though features
of intervention and trial design such as length of
follow-up and duration of intervention may not be as
important as the number of sessions provided [18].
Yet another review reported that positive effects may
be attributable to longer-term interventions with a
shorter duration between the end of the intervention
and the follow-up evaluation point [22]. On the other
hand, it has been found that self-care management in-
terventions may have a higher effect if the programme
is compact with sessions closely grouped together [17].
Although these findings gives some directions for dia-
betes educators and other healthcare providers engaged
in group based DSME, the magnitude of the education
programme still remains as one area that needs further
investigation.
It has been suggested that education delivered by a
team of educators, with some degree of reinforcement of
that education made at additional points of contact, may
provide the best opportunity for improvements in pa-
tient outcomes [22]. In the present study, based on those
studies that reported HbA1C at 12 months, it was indi-
cated that the largest effect was seen when having a diet-
ician as the only educator, although this was only done
in two studies. The studies with only a diabetes specialist
nurse as educator also tended to do better than the stud-
ies with a group of different educators. However, due to
few studies no clear conclusion can be drawn whether
having one person delivering the intervention is best. In
addition, studies with one person delivering the inter-
vention could measure that person's ability and engage-
ment more than the actual content and quality of the
intervention. Thus, transferring the same program deliv-
ered by one person in one study to another setting and
person might not give the same results. The implications
for those working clinically in this field is that if the pro-
gram is delivered by only one person, the clinical, peda-
gogical and personal qualities of this person should be of
the highest standards.
The five studies reporting having used a theoretical
model in the development of their DSME showed less
effect of the intervention. This indicates that having a
theoretical model underpinning the program is not
needed to achieve better results. Although it might be
that other studies used a theoretical model but did not
report this, it still raises the question about the useful-
ness of such models. One possible explanation is that
clinical experience with the input from participants
might provide an intervention that has better effect. This
should encourage diabetes educators and other health-
care providers engaged in group based DSME to include
participants in the planning, carrying out and evaluation
of the program.Conclusion
Based on current evidence, there are indications that
interventions delivered by a single educator, delivered in
less than ten months, with more than 12 hours and be-
tween 6 and 10 sessions give the best results but more
research is needed to confirm this. In general it can be
concluded that group-based DSME in people with type
2 diabetes results in improvements in clinical, lifestyle
and psychosocial outcomes.
Appendix A. Example of search strategy
MEDLINE
1. exp Patient Education/
2. exp Self Care/
3. exp Behavior Therapy/
4. exp Group Processes/
5. exp Psychotherapy, Group/
6. exp Self-Help Groups/
7. (empowerment or self care).tw,ot.
8. (patient$ adj6 education$).tw,ot.
9. behavio?r$ therap$.tw,ot.
10. (educational adj6 program$).tw,ot.
11. (self adj6 (care or efficac$ or help group$)).tw,ot.
12. (group$ adj6 (method$ or management$ or based
or process$ or psychotherap$)).tw,ot.
13. (physical adj6 (training$ or education$)).tw,ot.
14. or/1-13
15. exp Diabetes Mellitus, Type 2/
16. exp Diabetes Complications/
17. (MODY or NIDDM or T2DM).tw,ot.
18. (non insulin$ depend$ or noninsulin$ depend$ or
noninsulin?depend$ or non insulin?depend).tw,ot.
19. ((typ$ 2 or typ$ II) adj3 diabet$).tw,ot.
20. ((keto?resist$ or non?keto$) adj6 diabet$).tw,ot.
21. ((late or adult$ or matur$ or slow or stabl$) adj3
onset).mp. and diabet$.tw,ot.
22. or/15-21
23. exp Diabetes Insipidus/
24. diabet$ insipidus.tw,ot.
25. 23 or 24
26. 22 not 25
27. Meta-analysis.pt.
28. exp Technology Assessment, Biomedical/
29. exp Meta-analysis/
30. exp Meta-analysis as topic/
31. hta.tw,ot.
32. (health technology adj6 assessment$).tw,ot.
33. (meta analy$ or metaanaly$ or meta?analy$).tw,ot.
34. ((review$ or search$) adj10 (literature$ or medical
database$ or medline or pubmed or embase or
cochrane or cinahl or psycinfo or psyclit or healthstar
or biosis or current content$ or systemat$)).tw,ot.
35. or/27-34
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37. controlled clinical trial.pt.
38. randomi?ed.ab.
39. placebo.ab.
40. clinical trials as topic.sh.
41. randomly.ab.
42. trial.ti.
43. or/36-42
44. 35 or 43
45. (comment or editorial or historical-article).pt.
46. 44 not 45
47. 14 and 26 and 46
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